On December 31, 2015, Regeneron Pharmaceuticals (REGN) had a market capitalization of $62.2B, based on 115.66M shares at a price of $537.79.
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
December 2015 | $537.79 | 12,981,500 | 115,664,900 | $62,203,993,329.01 |
November 2015 | $539.41 | 15,062,800 | 115,664,900 | $62,390,769,009.53 |
October 2015 | $552.18 | 19,779,700 | 115,664,900 | $63,867,751,950.08 |
September 2015 | $460.79 | 20,759,500 | 115,944,000 | $53,426,021,270.40 |
August 2015 | $508.70 | 18,111,500 | 115,944,000 | $58,980,654,828.00 |
July 2015 | $548.48 | 13,328,200 | 115,944,000 | $63,593,440,490.40 |
June 2015 | $505.36 | 17,538,900 | 115,259,000 | $58,247,403,499.00 |
May 2015 | $507.77 | 15,383,600 | 115,259,000 | $58,524,866,489.70 |
April 2015 | $453.18 | 15,868,700 | 115,259,000 | $52,233,465,500.60 |
March 2015 | $447.26 | 21,053,400 | 115,183,300 | $51,516,802,129.69 |
February 2015 | $409.97 | 16,313,000 | 115,183,300 | $47,221,835,720.96 |
January 2015 | $412.76 | 17,185,100 | 115,183,300 | $47,543,611,787.84 |
December 2014 | $406.41 | 16,987,000 | 114,295,300 | $46,451,301,490.44 |
November 2014 | $412.22 | 15,016,100 | 114,295,300 | $47,114,808,566.00 |
October 2014 | $390.04 | 20,885,900 | 114,295,300 | $44,579,658,805.29 |
September 2014 | $357.15 | 16,774,200 | 117,423,000 | $41,937,589,223.10 |
August 2014 | $347.18 | 13,941,100 | 117,423,000 | $40,767,351,605.10 |
July 2014 | $313.26 | 19,959,800 | 117,423,000 | $36,784,375,187.40 |
June 2014 | $279.83 | 18,323,800 | 113,354,100 | $31,719,798,455.13 |
May 2014 | $304.09 | 15,361,600 | 113,354,100 | $34,469,893,610.64 |
April 2014 | $294.11 | 21,935,800 | 113,354,100 | $33,339,084,444.45 |
March 2014 | $297.47 | 27,725,200 | 112,151,000 | $33,361,871,992.80 |
February 2014 | $329.39 | 23,679,800 | 112,151,000 | $36,941,597,331.60 |
January 2014 | $285.89 | 19,504,800 | 112,151,000 | $32,063,084,907.10 |
December 2013 | $272.67 | 14,237,000 | 112,557,000 | $30,690,568,263.30 |